New device trains your head to beat motion sickness

NCT ID NCT05622344

Recruiting now Symptom relief Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called SWAN that guides people through head movements to reduce motion sickness and improve balance. It is for adults with inner ear disorders, motion sickness, or those recovering from vestibular schwannoma surgery. Participants use the device at home for 15-minute sessions while their eye and head movements are tracked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: StableEyes Training Device with video-oculography (SWAN)
What this could lead to: If it works, this could offer a simple, self-administered way to reduce motion sickness and improve balance for people with inner ear disorders or after vestibular schwannoma surgery.
What could go wrong: This is an early-stage trial with only 48 participants, so results may not apply to everyone. The device requires active participation and may not work for all types of motion sickness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOTION SICKNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acoustic neuroma motion sickness space motion sickness vestibular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MOTION SICKNESS SPACE MOTION SICKNESS VESTIBULAR DISORDER VESTIBULAR SCHWANNOMA

Contacts and locations

Locations

Johns Hopkins University
RECRUITING

Baltimore, Maryland, 21287, United States
Naval Medical Research Unit
ENROLLING_BY_INVITATION

Dayton, Ohio, 45433, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.